HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dhifaf Sarhan Selected Research

Dhifaf Sarhan Research Topics

Disease

22Neoplasms (Cancer)
11/2022 - 03/2012
2Lung Neoplasms (Lung Cancer)
01/2021 - 01/2021
2Melanoma (Melanoma, Malignant)
12/2020 - 08/2014
1Sarcoma (Soft Tissue Sarcoma)
11/2021
1Adenocarcinoma of Lung
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Cytokine Release Syndrome
03/2018
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2018
1Graft vs Host Disease (Graft-Versus-Host Disease)
03/2018
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2016
1Pathologic Complete Response
10/2014
1Ataxia Telangiectasia (Louis Bar Syndrome)
03/2012
1Breast Neoplasms (Breast Cancer)
03/2012

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
01/2021 - 10/2016
3Interleukin-2 (IL2)IBA
01/2021 - 01/2017
3AntibodiesIBA
12/2020 - 10/2014
3LigandsIBA
10/2017 - 03/2012
2Scavenger Receptors (Scavenger Receptor)IBA
01/2021 - 12/2020
2Interleukin-15 (Interleukin 15)IBA
01/2021 - 01/2018
2Dinoprostone (PGE2)FDA Link
01/2021 - 08/2014
2TNF-Related Apoptosis-Inducing LigandIBA
12/2020 - 01/2013
2Phosphotransferases (Kinase)IBA
10/2017 - 03/2012
2VaccinesIBA
10/2017 - 06/2015
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
10/2014 - 01/2013
1Biomarkers (Surrogate Marker)IBA
11/2022
1Biological ProductsIBA
01/2021
1Prostaglandin-E SynthasesIBA
01/2021
1SeleniumIBA
01/2021
1Interferon-gamma (Interferon, gamma)IBA
01/2021
1Complement System Proteins (Complement)IBA
12/2020
1Immune Checkpoint InhibitorsIBA
01/2019
1Rituximab (Mabthera)FDA Link
03/2018
1Toll-Like Receptor AgonistsIBA
10/2017
1Peptides (Polypeptides)IBA
10/2017
1InterferonsIBA
10/2017
1EpitopesIBA
10/2017
1Poly I-CIBA
10/2017
1Zoledronic Acid (Zometa)FDA Link
01/2017
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2016
1AntigensIBA
01/2015
1HLA-DR Antigens (HLA-DR)IBA
08/2014
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2014
1AnthracyclinesIBA
10/2013
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2013
1Anti-Bacterial Agents (Antibiotics)IBA
10/2013
1Caspase 8 (Caspase-8)IBA
10/2013
1Death Domain ReceptorsIBA
10/2013
1CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
10/2013
1Proteasome Endopeptidase Complex (Proteasome)IBA
08/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2013
1Bortezomib (Velcade)FDA Link
08/2013
1Proteasome InhibitorsIBA
08/2013
1ErbB Receptors (EGF Receptor)IBA
10/2012
1tyrosine receptor (receptor, tyrosine)IBA
03/2012
1Protein Kinases (Protein Kinase)IBA
03/2012
1Caffeine (No Doz)FDA LinkGeneric
03/2012
1micaIBA
03/2012
1NeuregulinsIBA
03/2012
1MHC class I-related chain AIBA
03/2012

Therapy/Procedure

8Immunotherapy
11/2021 - 10/2012
6Therapeutics
01/2021 - 08/2014
1Cell- and Tissue-Based Therapy (Cell Therapy)
10/2013
1Ligation
01/2013